When did Upstream Bio, Inc. report Q1 2025 earnings?

Upstream Bio, Inc. (UPB) reported Q1 2025 earnings on May 6, 2025 before market open.

What were Upstream Bio, Inc.'s Q1 2025 revenue and EPS?

Upstream Bio, Inc. reported revenue of $566.0K and diluted EPS of $-0.51 for Q1 2025.

Did Upstream Bio, Inc. beat estimates in Q1 2025?

Revenue beat the consensus estimate of $317.0K by $249.0K. EPS missed the consensus estimate of $-0.49 by $0.02.

Where can I find Upstream Bio, Inc.'s Q1 2025 SEC filings?

You can read the 10-Q periodic report (0000950170-25-063957) directly on SEC EDGAR. The filing index links above go to sec.gov.

Upstream Bio, Inc. UPB Q1 2025 earnings

Reported May 6, 2025 · Before market open

Revenue$566.0KBeat by $249.0K Diluted EPS-$0.51Miss by $0.02

Revenue estimate$317.0K

EPS estimate-$0.49

Next report

Aug 5, 2026 (In 3 weeks)

Revenue estimate$431.1K

EPS estimate-$0.78

Financials

Q1 2025

Income statement

See full

Revenue$566.0K-11.6%

Operating income-$32.0M-113%

Net income-$27.3M-150%

EPS (diluted)-$0.51+89.1%

Balance sheet

See full

Cash & equivalents$71.3M+126%

Total debt$1.7M—

Total equity$445.6M+434%

Total assets$456.2M—

Cash flow

See full

Operating cash flow-$41.2M-134%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$328.28M—

Enterprise value$258.67M—

P/S143×—

Profitability

See full

Operating margin-4,127.4%—

Net margin-3,448.7%—

Returns & leverage

See full

Debt / equity0×—

Current ratio47.4×—

Versus estimates

Revenue

Q1 2026$1.0MBeat by $6.3K Q4 2025$668.0KBeat by $84.0K Q3 2025$683.0KBeat by $161.4K Q2 2025$937.0KBeat by $620.0K

Q1 2025$566.0KBeat by $249.0K

Q4 2024$613.0KBeat by $286.8K

Diluted EPS

Q1 2026-$0.75Miss by $0.01 Q4 2025-$0.79Miss by $0.06 Q3 2025-$0.63Beat by $0.15 Q2 2025-$0.74Miss by $0.13

Q1 2025-$0.51Miss by $0.02

Q4 2024-$1.59Miss by $1.03

Ask the moment Upstream Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Upstream Bio, Inc. report Q1 2025 earnings?: Upstream Bio, Inc. (UPB) reported Q1 2025 earnings on May 6, 2025 before market open.
What were Upstream Bio, Inc.'s Q1 2025 revenue and EPS?: Upstream Bio, Inc. reported revenue of $566.0K and diluted EPS of $-0.51 for Q1 2025.
Did Upstream Bio, Inc. beat estimates in Q1 2025?: Revenue beat the consensus estimate of $317.0K by $249.0K. EPS missed the consensus estimate of $-0.49 by $0.02.
Where can I find Upstream Bio, Inc.'s Q1 2025 SEC filings?: You can read the 10-Q periodic report (0000950170-25-063957) directly on SEC EDGAR. The filing index links above go to sec.gov.